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Similar to other herpesviruses, human cytomegalovirus remains in the infected host following resolution of the primary
infection. The ability to persist in the host after primary infection is believed to be strongly influenced by the ability of HCMV
to down-regulate immune recognition of infected cells. One of the genes contributing to immune evasion is the US3 gene.
The US3 gene has been shown to retain major histocompatibility complex type I molecules in the endoplasmic reticulum. The
US3 gene gives rise to three alternatively spliced RNAs which encode distinct but related proteins. Each of the alternatively
spliced transcripts is present early in viral infection, suggesting that the encoded proteins play a role in the viral life cycle.
We demonstrate that only the protein encoded by the unspliced US3 transcript is able to retain MHC class I heavy chains
in the endoplasmic reticulum. The protein encoded by the singly spliced US3 transcript appears to be processed through the
secretory pathway while the protein encoded by the doubly spliced transcript becomes localized to the Golgi apparatus.
These experiments raise interesting questions about the functions of the smaller US3 proteins during viral infection in theINTRODUCTION
Human cytomegalovirus (HCMV) is a common subclin-
ical viral infection. In immunocompromised individuals
and neonates, HCMV infection can result in clinically
significant disease and even death (Britt and Alford,
1996). Primary infection is followed by the establishment
of a latent or persistent viral infection. Establishment of a
latent infection is thought to be facilitated by viral eva-
sion of the immune system.
HCMV has evolved numerous strategies to avoid de-
tection and elimination by the immune system, with dif-
ferent strategies utilized at different time periods during
viral replication. Immediately following infection, the
virion protein pp65 (ppUL83) interferes with antigenic
presentation of the major immediate early proteins
(pUL122–123) by an as yet unidentified mechanism (Gil-
bert et al., 1996). Expression of the immediate early US3
gene results in retention of major histocompatibility com-
plex (MHC) class I protein complexes in the endoplasmic
reticulum (ER) (Ahn et al., 1996; Jones et al., 1996). During
early times of viral infection, US2 and US11 gene prod-
ucts cause the export of MHC class I complexes into the
cytosol where the class I heavy chains are degraded
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32(Jones et al., 1995; Wiertz et al., 1996a,b). US2 also
causes degradation of proteins involved in MHC class II
antigen presentation (Tomazin et al., 1999). Another gene
product, the US6 gene product, interferes with the trans-
porter for antigen presentation (TAP) activity and loading
of peptide antigens onto the MHC class I complex (Hen-
gel and Koszinowski, 1997; Ahn et al., 1997; Sadasivan et
al., 1996). Late in viral infection, expression of HLA-E is
enhanced by the viral glycoprotein gpUL40, allowing
infected cells to avoid destruction by natural killer cells
(Tomasec et al., 2000). Additionally, the HCMV gene
UL111a encodes a homolog of IL-10, a cytokine with
immunosuppressive and anti-inflammatory effects (Ko-
tenko et al., 2000).
The US3 gene is the first viral gene to be transcribed
following infection that contributes to immune evasion.
Three alternatively spliced mRNA species are generated
from the US3 gene; these RNAs encode distinct but
related proteins of 3.5, 17, and 21.6 kDa when translated
in vitro (Weston, 1988; Tenney et al., 1993). All of the
predicted protein products have a potential signal pep-
tide; the 21.6-kDa protein also contains a predicted trans-
membrane domain. The 17- and 21.6-kDa proteins have
134 amino acids in common, including two cysteine
residues and a glycosylation signal present in exon 3.
The 17- and 21.6-kDa proteins are modified by glycosyl-
ation when translated in vitro, in the presence of canine
pancreatic microsomes. Expression of the US3 gene in
different cell types has demonstrated that US3 expres-host. © 2002 Elsevier Science (USA)
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retaining these proteins in the ER (Jones et al., 1996; Ahn
et al., 1996). Coprecipitation of a 22-kDa US3 protein with
MHC class I molecules suggests that this protein is
critical for retention of MHC class I heavy chains in the
ER (Ahn et al., 1996; Jones et al., 1996). Work by Lee et al.
(2000) further suggests that the ER lumenal and trans-
membrane domains of the 22-kDa US3 protein are suf-
ficient for retention of MHC class I molecules. The pos-
sible contributions of the smaller US3 proteins to MHC
class I molecule retention were not analyzed in these
studies (Jones et al., 1996; Ahn et al., 1996; Jun et al.,
2000). In this article we examined the effects of the
individual US3 proteins on MHC class I molecules. Anal-
ysis of cell lines expressing individual US3 proteins dem-
onstrated that the large US3 protein alone is sufficient for
MHC class I molecule retention. We further demonstrate
that the singly spliced US3 transcript encodes a protein
of 17 kDa; this protein appears to traffic through the
secretory pathway. Several interesting questions still re-
main to be answered, including the roles of the 17- and
3.5-kDa proteins in viral infection.
RESULTS
Expression of the US3 gene
The US3 gene has been defined as an immediate early
gene, with transcription of the gene occurring following
infection in the absence of de novo protein synthesis
(Weston, 1988). Similar to many of the other immediate
early genes of HCMV, the US3 gene encodes multiple
alternatively spliced transcripts: a full-length unspliced
transcript, a singly spliced transcript, and a doubly
spliced transcript (Fig. 1A) (Tenney et al., 1993). The US3
transcripts appear by 1 h postinfection, with peak accu-
mulation of transcripts occurring at 3 hpi, followed by a
marked decline in transcript levels by 5 hpi (Biegalke,
1995; Greijer et al., 2001). Isolation of cDNAs clones
representative of each of the transcripts suggests that
the spliced RNAs accumulate preferentially in the ab-
sence of protein synthesis and further suggests that the
full-length transcript is the most abundant US3 message
(Tenney et al., 1993). We used RNase protection assays
to determine the relative abundance of each of the alter-
natively spliced US3 transcripts at various times follow-
ing HCMV (Towne) infection of human diploid fibroblasts.
An antisense radiolabeled probe (see Fig. 1A) generated
from the HCMV strain AD169 full-length cDNA was used
for the detection of the US3 transcripts. The protected
RNA fragments were predicted to be 291, 251, or 161
nucleotides in length, corresponding to the unspliced,
singly spliced, or doubly spliced transcripts, respectively.
An RNA probe protected by glyceraldehyde phosphate
dehydrogenase transcripts was used as an internal stan-
dard.
US3 transcripts were first detected 1 h postinfection
with the level of transcripts increasing until 3 to 4 hpi
(Fig. 1B). By 5 hpi, all three forms of the US3 RNAs were
beginning to decline in abundance, confirming the North-
ern blot analysis of US3 transcript levels (Biegalke, 1995).
Quantitative analysis, comparing the amounts of the pro-
tected US3 fragments to levels of the cellular message,
GPDH, demonstrated that the unspliced US3 transcript
was the most abundant message at 1–3 h of infection
(Fig. 1C). The levels of the singly spliced transcript were
somewhat lower than those of the full-length transcript;
the levels of these two transcripts varied with similar
kinetics (Fig. 1C). In contrast to the full-length and singly
spliced transcripts, the doubly spliced transcript accu-
mulated and declined with delayed kinetics compared to
the larger transcripts. The level of the doubly spliced
transcripts was maximal at 4 hpi, declining slightly in
abundance by 5 hpi (Figs. 1B and 1C). All three alterna-
tively spliced forms of the US3 transcripts were clearly
present early in infection, suggesting that the encoded
proteins play a role in viral infection in the infected host.
In the RNase protection assays, the sizes of the pro-
tected fragments corresponding to the full-length and
singly spliced transcripts were smaller than predicted by
approximately 15 nucleotides. Comparison of RNase pro-
tection assay results obtained using RNA from cells that
contain HCMV strain Towne or strain AD169 US3 se-
quences revealed differences in the sizes of the pro-
tected fragments (see Fig. 2). To determine the basis of
the size variation in the protected fragments, the HCMV
strain Towne US3 gene was sequenced. Seven nucleo-
tide changes were identified, with three of the nucleotide
changes located near the 3 end of the probe used for
the RNase protection assays (Fig. 1A). The three-nucle-
otide mismatch resulted in additional digestion of the
RNA probe when hybridized to Towne US3 transcripts,
resulting in a decrease of 15 bp in the protected frag-
ment, accounting for the discrepancy between the pre-
dicted and observed sizes of the protected fragments.
Five of the nucleotide changes seen in HCMV strain
Towne resulted in amino substitutions in the encoded
US3 proteins (see Table 1 and Fig. 1A). None of the
amino acid changes were in the signal peptide or trans-
membrane domain.
The singly spliced US3 transcript encodes a 17-kDa
protein
Two polypeptides of 22 and 17 kDa were detected in
US3-expressing cell lines and virally infected cells (Ahn
et al., 1996; Jones et al., 1996). The 17-kDa peptide was
postulated to be either the translation product of a
spliced US3 transcript, or alternatively, the immature
form of the 22-kDa protein. To definitively identify the
protein products encoded by the unspliced and singly
spliced US3 RNAs, a number of cell lines were gener-
ated that express US3 sequences. To generate the cell
lines, US3 cDNAs (from strain AD169), a truncated cDNA
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corresponding to the unspliced transcript but lacking
exon 5, or the genomic US3 sequence (from strain Towne
and equivalent to the cDNA corresponding to the un-
spliced transcript), were inserted into the plasmid vector
pIRES-neo. Plasmids were transfected into the U373
glioblastoma cell line and neomycin-resistant cell clones
were isolated. The resulting cell lines were analyzed for
US3 transcripts using RNase protection assays; a mini-
mum of four different cell lines constructed with each of
the US3-expression plasmids was analyzed for US3 tran-
scripts.
RNase protection analyses of RNA isolated from the
cell lines containing the cDNA corresponding to the
AD169 unspliced transcript (US-cDNA) or the Towne
genomic US3 sequences revealed two protected frag-
ments corresponding to the unspliced and singly spliced
US3 transcripts (Fig. 2A, Lanes 9–12). The strain-specific
variation in the size of the protected fragments resulted
from nucleotide changes as discussed above. Some-
what surprisingly, the doubly spliced transcript was not
detected in cell clones expressing either the AD169
US-cDNA or the Towne genomic sequences. Analyses of
cells containing the AD169 US3 US-cDNA also revealed
cell clone-specific protected fragments that are pre-
sumed to correspond to aberrantly spliced RNAs (Fig.
2A).
A predominant fragment corresponding to the un-
spliced US3 transcript was protected using RNA from
cell lines expressing the truncated cDNA composed of
exons 1 through 4 (US3ex5; Fig. 2A, Lanes 7 and 8).
Spliced US3 transcripts in these cell lines were predicted
to be degraded through the nonsense-mediated degra-
dation pathway. Detection of only a low level of the
protected fragments corresponding to the singly spliced
transcript confirmed this prediction. RNase protection
assays of RNA from cell clones containing the cDNA
generated from the singly spliced (SS-cDNA) or the dou-
indicted by the black rectangles; dotted lines indicate splicing events
(Tenney et al., 1993; Weston, 1988). (B) RNase protection assays. RNase
protection assays were performed on whole-cell RNA isolated from
mock-infected (M) or from HCMV strain Towne-infected human diploid
fibroblasts at the indicated times postinfection (h). The probes (P) for
the internal standard, glyceraldehyde phosphate dehydrogenase
(GPDH), and US3 transcripts are indicted by an * and and o, respec-
tively. P, yeast tRNA and the probes treated with the RNase mixture;
GPDH, protected fragments corresponding to levels of the cellular
message; US, SS, and DS, protected fragments corresponding to un-
spliced, singly spliced, or doubly spliced US3 transcripts, respectively.
S, RNA molecular weight markers with the size indicated in nucleo-
tides. (C) Quantification of US3 transcripts. Protected fragments corre-
sponding to US, SS, and DS US3 transcripts were quantified by a
scanning densitometer using Molecular Dynamic software. Levels of
US3 transcripts were determined by normalizing to the density of the
smaller GPDH protected fragment and correcting for the number of U
residues present in the protected fragment. Levels of US3 transcripts
were plotted vs hours postinfection. F, unspliced US3 mRNA; f, singly-
spliced US3 mRNA; and Œ, doubly spliced US3 mRNA.
FIG. 1. Analysis of US3 expression. (A) Diagram of the US3 transcrip-
tion unit. Numbered rectangles represent exons; vertical arrows depict
positions of amino acid changes; the horizontal arrow corresponds to
the probe used for RNase protection assays; open rectangles repre-
sent 5 and 3 untranslated regions of the US3 transcripts; gray rec-
tangles represent protein coding regions; shared amino acids are
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bly spliced transcript (DS-cDNA) detected protected frag-
ments of the predicted sizes, 251 and 161 nucleotides,
respectively, that correspond to singly and doubly
spliced RNAs (Fig. 2A, Lanes 3–6). Control cell lines that
contained the plasmid vector but no US3 sequences did
not yield any protected fragments corresponding to US3
transcripts (data not shown).
US3 proteins present in the cell lines were analyzed by
immunoprecipitation experiments, using polyclonal anti-
sera to amino acids 33 to 113 of the US3 open reading
frame (Jones et al., 1996). Cells expressing the entire US3
open reading frame (either the AD169 US-cDNA or the
Towne genomic sequence) contained two US3 proteins of
22 and 17 kDa (Fig. 2B, Lanes 1, 2, and 7). Cell lines
expressing the SS-cDNA synthesized a US3 protein of 17
kDa (Fig. 2B, Lanes 5 and 6). Cell lines containing the
truncated cDNA (lacking exon 5) synthesized a single US3
protein of 22 kDa (Fig. 2B, Lane 4). These data demon-
strated that the 22-kDa protein is encoded by the unspliced
US3 RNA and that the 17-kDa US3 protein is the translation
product of the singly spliced transcript. Although we con-
structed cell lines that express the doubly spliced US3
transcript (Fig. 2A, Lanes 3 and 4), we were unable to
demonstrate synthesis of the encoded protein as no re-
agents are currently available that react with the predicted
peptide. By comparison with the cell clones expressing
other forms of the US3 RNAs, we expect that the 3.5-kDa
protein is synthesized in these cells. No proteins were
precipitated from the control cell lines with the anti-US3
antiserum (Fig. 2B, Lanes 3 and 8).
Functional analysis of the US3 proteins
The involvement of the different US3 proteins in reten-
tion of MHC class I molecules in the ER was assayed
using the cell lines described above. To determine the
TABLE 1
US3 Amino Acid Variation






a Single letter amino acid code.
FIG. 2. (A) RNase protection analyses of representative cell lines
expressing US3 transcripts. Stable US3-expressing U373 cell lines
were established using the pIRESneo-derived plasmids, pBJ317 [which
expresses the cDNA corresponding to the unspliced AD169 US3 tran-
script (US)], pBJ380 [which expresses a truncated cDNA derived from
the unspliced AD169 US3 transcript with exon 5 deleted (US5)],
pBJ318 [which expresses the cDNA corresponding to the singly spliced
AD169 US3 transcript (SS)], pBJ319 [which expresses the cDNA corre-
sponding to the doubly spliced US3 transcript (DS)], or pB320 [which
expresses the Towne US3 genomic sequence (Towne)]. The probe
depicted in Fig. 1 was used to detect US3 transcripts in total RNA
isolated from the stable cell lines. Probe fragments corresponding to
the unspliced (US), singly spliced (SS), and doubly spliced transcripts
(DS) are indicated. Lane 1, probe alone (P); Lane 2, probe plus RNAses
(P); Lane 3, RNA from cell line 319-1; Lane 4, RNA from cell line 319-2;
Lane 5, RNA from cell line 318-4; Lane 6, RNA from cell line 318-6; Lane
7, RNA from cell line 380-3; Lane 8, RNA from cell line 380-4; Lane 9,
RNA from cell line 317-B2; Lane 10, RNA from cell line 317-1; Lane 11,
RNA from cell line 320-4; Lane 12, RNA from cell line 320-1; Lane 13,
RNA from HCMV strain Towne-infected HDF’s 4 h postinfection (I). (B)
Analysis of US3 proteins in the U373 cell lines. The stable US3-
expressing cell lines were radiolabeled using [35S]methionine-cysteine
(EasyTag, New England Nuclear) prior to immunoprecipitation with
polyclonal antiserum to US3 proteins (kindly provided by T. Jones). A
minimum of four individual cell lines derived by introduction of the
indicated plasmid into U373 cells was analyzed; representative data
are presented for the indicated cell lines. Lane 1, cells expressing the
Towne US3 gene (cell line 320-4); Lane 2, cells expressing US3 se-
quences corresponding to the AD169-unspliced transcript (cell line
317-B2); Lane 3, control cells with no US3 sequences (cell line GFP-4);
Lane 4, cells expressing US3 sequences corresponding to AD169
exons 1–4 (AD169ex5, cell line 380-3); Lanes 5 and 6, cells expressing
the cDNA corresponding to the singly spliced AD169 transcript (Lane 5,
cell line 318-5; Lane 6, cell line 318-6); Lane 7, cell line 317-B2; Lane 8,
cell line GFP-4.
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effects of the US3 proteins on the maturation of MHC
class I molecules, cells were treated with a pulse of
radioactive amino acids and then either harvested im-
mediately or subjected to a chase with nonradioactive
amino acids prior to harvest. Cell lysates were immuno-
precipitated with monoclonal antibody W6/32, an anti-
body that recognizes the MHC class I complex. The
immunoprecipitates were divided into two aliquots and
either treated with endoglycosidase H or mock-treated.
Oligosaccharide chains present on proteins retained in
the ER are sensitive to endoglycosidase H digestion;
removal of the oligosaccharides by endoglycosidase H is
indicated by a decrease in protein size. Four different cell
lines constructed with each of the US3-expression plas-
mids were analyzed for MHC class I molecule retention;
representative data from one of each of the cell lines
analyzed is shown in Fig. 3.
In all of the cell lines examined, after a 30-min labeling
period, the majority of the MHC class I molecules was
sensitive to endoglycosidase H treatment. This reflected
the de novo synthesis of the proteins and insufficient
time for the proteins to traffic from the ER to the Golgi. In
the control cell line, a 2-h chase with nonradioactive
amino acids was sufficient for processing of the MHC
class I molecules and associated maturation of the oli-
gosaccharide chains, making them largely resistant to
FIG. 3. Retention of MHC class I molecules by US3 proteins. Cells constitutively expressing the alternatively spliced transcripts of the US3 gene
were radiolabeled with [35S]methionine, and then either immunoprecipitated with a monoclonal antibody to MHC class I molecules (W6/32) or
subjected to a 2-h chase with nonradioactive amino acids (Chase) prior to immunoprecipitation. Following immunoprecipitation, complexes were
divided into two aliquots and either mock-digested or digested with endoglycosidase H (EndoH). Immunoprecipitates were analyzed by SDS–PAGE
and autoradiography. AD169-US, cell line 317-B2, which expresses the cDNA corresponding to the AD169-unspliced US3 transcript, Lanes 13–16;
AD169-USex5, cell line 380-3 which expresses the AD169 unspliced cDNA with exon 5 deleted, Lanes 21–23; cell line 318-6 expresses the cDNA
corresponding to the singly spliced AD169 US3 transcript, Lanes 17–20; Control, cell line GFP-4, which expresses GFP, Lanes 1–4; Towne-US, cell
line 320-4, which expresses the HCMV strain Towne genomic sequence, Lanes 5–8; and AD169-DS, cell line 319-4 which expresses the cDNA
corresponding to the doubly spliced AD169 US3 transcript, Lanes 9–12. Four individual cell lines derived from each of the plasmids were analyzed;
data from representative cell lines are shown above. HC, MHC class I heavy chains; 2M, beta-2-microglobulin.
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endoglysosidase H digestion (Fig. 3, compare Lanes
1–4). In contrast, in cells expressing the 17- and 22-kDa
US3 proteins, the MHC class I heavy chains remained
predominantly endoglycosidase H sensitive following
the chase period (Fig. 3, Lanes 5–8 and 13–16). Similarly,
in the cell line expressing only the 22-kDa US3 protein,
the oligosaccharides on the MHC class I heavy chains
remained largely sensitive to endoglycosidase H diges-
tion, indicating retention of the proteins in the ER (Fig. 3,
compare Lanes 21–24). These data demonstrated that
expression of the 22-kDa US3 protein alone was suffi-
cient for retention of MHC class I molecules in the ER.
The 17-kDa US3 protein and the 22-kDa have a large
number of amino acids in common, suggesting that the
17-kDa protein, similar to the 22-kDa protein, could po-
tentially have an effect on maturation of MHC class I
molecules. Pulse-chase experiments were also per-
formed with the cell lines expressing only the 17-kDa
protein. Following the chase period, the MHC class I
heavy chains became endoglycosidase H resistant, sim-
ilar to the control cells (Fig. 3, Lanes 17–20), demonstrat-
ing that the 17-kDa protein is unable to retain MHC class
I molecules in the ER. Coprecipitation experiments dem-
onstrated that the 17-kDa protein does not physically
associate with MHC class I molecules, confirming the
results of Ahn et al. (1996) and Jones et al. (1996). Like-
wise, expression of the doubly spliced transcript had no
effect on the maturation of MHC class I molecules (Fig.
3, Lanes 9–12). These data demonstrated that the do-
main for retaining MHC class I heavy chains in the ER is
not present in the 134 amino acids that are common
between the 17- and 22-kDa proteins. Thus, the domain
for retaining MHC class I molecules in the ER resides in
the COOH-terminal 52 amino acids of the 22-kDa US3
protein. The COOH-terminal amino acids also appear to
be critical for the protein–protein interactions as only the
22-kDa protein coprecipitates with the MHC class I mol-
ecules (Jones et al., 1996; Ahn et al., 1996) and the
physical association appears to play an important role in
alteration of the MHC class I molecule processing (Zhao
et al., unpublished data).
Intracellular distribution of US3 proteins
Immunofluorescence analysis of the intracellular loca-
tion of US3 proteins identified the proteins as residents
of the ER (Ahn et al., 1996; Jones et al., 1996). Lee et al.
(2000) identified the ER lumenal portion of the 22-kDa
US3 protein as containing the intracellular ER localiza-
tion signal. This contrasts with other ER resident proteins
where retrieval to the ER is a function of the amino acid
sequence in the cytoplasmic tail of the protein. This
suggested that the 17- and the 22-kDa US3 proteins
would both localize to the ER as they have 134 amino-
terminal amino acids in common, which includes the
majority of the ER lumenal domain of the 22-kDa protein
(See Fig. 1A). We examined the intracellular location of
the US3 proteins by expressing US3-enhanced green
fluorescent protein (EGFP) fusion proteins, in which the
carboxyl-terminal end of the US3 protein was extended
with the open reading frame of EGFP. The cDNAs repre-
senting each of the spliced variants of the US3 tran-
scripts was inserted in-frame with EGFP; the resulting
plasmids were transfected into HeLa cells. Indirect im-
munofluorescence was used to label the ER or the Golgi
apparatus, using antibodies to protein disulfide isomer-
ase, a resident lumenal ER protein, or to human golgin-
97, a resident protein of the Golgi apparatus, respec-
tively. Transfected cells were identified by green fluores-
cence; nuclei were stained with DAPI and visualized by
their blue fluorescence. Brefeldin A treatment was used
to identify proteins trafficking through the Golgi and
trans-Golgi network. Brefeldin A disrupts the Golgi ap-
paratus, resulting in a rapid relocation of proteins in the
Golgi to the ER (Sciaky et al., 1997). Fluorescence micro-
graphs of representative fields containing transfected
cells are shown in Fig. 4.
The 22-kDa US3-EGFP protein was predominantly lo-
calized to the ER as demonstrated by colocalization of
US3-EGFP with PDI, and by the lack of a Brefeldin A
effect on the pattern of green fluorescence (Figs. 4B and
4C), confirming and extending published reports (Jones
et al., 1996; Ahn et al., 1996; Lee et al., 2000). The 17-kDa
EGFP fusion protein, although found partially in the ER,
was also located in the Golgi and in vesicles in the
cytoplasm (Fig. 4). The pattern of green fluorescence
was disrupted by Brefeldin A treatment, which resulted in
localization of the green fluorescence to the ER. These
data suggested that the 17-kDa US3 protein is processed
through the secretory pathway. The putative 3.5-kDa US3
protein was also expressed as an EGFP-fusion protein.
In contrast to the results observed with the larger US3
proteins, the 3.5-kDa US3-EGFP fusion protein localized
to the Golgi apparatus (Fig. 4). Brefeldin A treatment
disrupted the pattern of 3.5-kDa US3-EGFP fluorescence,
redistributing the green fluorescence to a pattern that
colocalized with PDI (Fig. 4C). Addition of EGFP to the
3.5-kDa protein is a significant modification of the US3
protein; generation of reagents able to specifically detect
the 3.5-kDa protein is needed to determine whether the
native protein localizes to the Golgi apparatus.
DISCUSSION
Retention of MHC class I heavy chains in the ER is
mediated through the HCMV US3 gene, and specifically,
the 22-kDa US3 protein. However, the relative abun-
dance of all three transcripts encoded by the US3 gene
suggests that each of the encoded proteins contributes
to the viral life cycle in the infected host. Comparison of
the levels of the different US3 transcripts, particularly in
cell lines expressing the entire US3 gene, suggests that
37HCMV US3 PROTEINS
splicing of the primary US3 transcript is regulated, per-
haps by splice site repressors or by viral proteins. The
experiments presented above are the first to demon-
strate that proteins encoded by alternatively spliced
forms of US3 transcripts do not play a role in inhibiting
the maturation of the MHC class I heavy chains. The
function of the US3 gene and the 22-kDa protein in
immune evasion is strain-independent despite amino
acid variations in the open reading frames of HCMV
strains AD169 and Towne.
The 17-kDa US3 protein is highly related to the 22-kDa
protein; the two proteins differ only at the COOH end,
including the absence of a transmembrane domain in the
17-kDa protein. The 17-kDa protein was unable to retain
FIG. 4. Fluorescence microscope localization of US3-EGFP fusion proteins. Cells were transfected with plasmids expressing the 22 kDa (us), 17
kDa (ss), or 3.5 kDa (ds) US3 proteins as EGFP-tagged proteins. Cells were either left untreated (A, B) or were treated with Brefeldin A (C). Nuclei
were stained with DAPI and visualized using blue fluorescence (DAPI); the resident ER protein, protein disulfide isomerase (PDI; B and C), and the
resident Golgi apparatus protein, golgin-97 (A) were detected using indirect immunofluorescence with the secondary antibody conjugated to Texas
red (PDI). The composite images are the sum of the blue, green, and red fluorescence. Cells are magnified 1000.
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MHC class I molecules in the ER and also does not
coprecipitate with MHC class I molecules (Jones et al.,
1996; Ahn et al., 1996; Zhao et al., unpublished data).
These data support the conclusion of Lee et al. (2000),
where the US3 transmembrane domain is required for
retention of MHC class I molecules in the ER. The 17-kDa
protein appeared to be processed through the secretory
pathway, suggesting that the COOH-terminal 52 amino
acids unique to the 22-kDa protein contain an ER reten-
tion signal. A function for the 17-kDa protein has yet to be
identified.
Evidence for in vivo synthesis of the 3.5-kDa US3
protein is still lacking. The RNase protection assays
clearly indicate that the transcript encoding this pre-
dicted protein is expressed during viral infection. Expres-
sion of the open reading frame of the 3.5-kDa protein as
an EGFP-tagged protein resulted in localization of the
green fluorescence to the Golgi apparatus. The localiza-
tion of the fusion protein is surprising and intriguing. The
3.5-kDa EGFP fusion protein lacks a transmembrane
domain characteristic of enzymes that localize to the
Golgi. Identification and localization of the 3.5-kDa pro-
tein during infection are needed to confirm the results
seen with the EGFP-tagged protein.
Alteration of antigen presentation by MHC class I
molecules is a common strategy used by viruses to
evade detection by the host immune system. The ade-
novirus E3-19k ER resident protein retains MHC class I
molecules in the ER through the interaction of the E3-19k
lumenal and transmembrane domains with MHC class I
molecules (Gabathuler et al., 1990). Murine cytomegalo-
virus (MCMV) encodes proteins that also interfere with
the presentation of antigens by MHC class I molecules.
The MCMV gene, m152, encodes a glycoprotein of 40
kDa that selectively retains mouse MHC class I heavy
chains in the ER–Golgi network (Ziegler et al., 1997). A
secreted form of the m152 protein is able to bind to MHC
class I molecules (Ziegler et al., 2000), in contrast with
the results presented here for US3 proteins. Deletion of
m152 attenuates MCMV, underscoring the importance of
immune evasion genes in the life cycle of the virus in the
natural host.
Given the likely importance of the US3 gene for viral
replication in the infected host, the short half-life of the
US3 22-kDa protein (60 min) (Ahn et al., 1996; Jones et
al., 1996), and the dramatic transcriptional down-regula-
tion of US3 expression early in infection are surprising.
Although US3 expression does not interfere with the
maturation of a cellular glycoprotein, the transferrin re-
ceptor, it is possible that maturation of viral glycoproteins
may be inhibited by continuous expression of the 22-kDa
US3 protein. Alternatively, continual expression of the 17-
and 3.5-kDa proteins may have deleterious effects on
viral replication.
The ability of the HCMV 22-kDa US3 protein to down-
regulate expression of the MHC class I heavy chains is
predicted to play an important role in the establishment
of infection in the host. The recent identification of the
FIG. 4—Continued
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role of MHC class I molecules in development of the
nervous system (Huh et al., 2000) suggests that HCMV
infection of the fetus with associated US3 expression
may interfere with normal brain development, possibly
contributing to the mental retardation seen in severely
affected infants.
MATERIALS AND METHODS
Cells, virus, and transfections
Human glioblastoma cells (U373 cells) were obtained
from Adam Geballe, Fred Hutchinson Cancer Research
Center (Seattle, WA); HeLa cells were obtained from
Clontech (Palo Alto, CA) and primary human diploid fi-
broblast cultures were established as previously de-
scribed (Biegalke, 1995). Human diploid fibroblasts,
HeLa, and U373 cells were propagated in Dulbecco’s
minimal essential medium (Gibco-BRL, Gaithersburg,
MD) supplemented with 10% NuSerum (Collaborative
Research Products, Bedford, MA), penicillin, streptomy-
cin, and glutamine. HCMV strain Towne was propagated
in primary human fibroblasts.
Transfections were performed using calcium phos-
phate. Briefly, cells (80–90% confluent) were fed with the
appropriate medium the day of the experiment. Plasmid
DNA (10 g) in a mixture of 0.125 M CaCl2 and 1 BBS
(50 mM BES pH 6.95, 280 mM NaCl, and 5 mM Na2HPO4)
was added to the medium overlaying the cells. Following
an overnight incubation in 3.5% CO2 at 35°C, the cells
were washed and fed with complete medium. U373 cell
clones containing stable plasmid integrants were se-
lected using complete medium containing 500 g/ml
G418.
RNA analysis
Total cellular RNA was isolated from infected cells or
stable transfected cell lines using acid-phenol gua-
nidium (Chomczynski and Sacchi, 1987). RNase protec-
tion assays were performed using the RPA II kit (Ambion,
Austin, TX) as recommended by the manufacturer; the
products of the assays were analyzed on 5% denaturing
polyacrylamide gels. For the synthesis of radiolabeled
RNA complementary to US3 messages, a 285-bp SphI-
KpnI fragment of the US3 gene was inserted into pBS
(Stratagene, La Jolla, CA) to generate pBJ335. Radiola-
beled antisense US3 RNA was transcribed using the
Maxiscript T7 kit (Ambion) and 32P-UTP. Century tem-
plates (Ambion) were transcribed to generate RNA mo-
lecular weight markers; an antisense glyceraldehyde
phosphate dehydrogenase (GPDH) transcript was used
as an internal standard. Quantification of the protected
US3 RNA fragments was performed using a scanning
densitometer and Molecular Dynamics software, normal-
izing the amounts of the US3 transcripts to the cellular
message, GPDH.
Sequence analysis
The DNA sequence of the HCMV strain Towne US3
open reading frame was determined by sequence anal-
ysis of pBJ174 (Biegalke, 1999) using gene-specific prim-
ers and the Sequenase kit (USB, Cleveland, OH) or the
Big Dye terminator kit (Perkin–Elmer, Foster City, CA).
The sequence of the HCMV strain Towne US3 open
reading frame is present in GenBank as Accession No.
AY038933.
Plasmids
pBJ317, pBJ318, pBJ319, and pBJ320 were constructed
by inserting the cDNAs corresponding to the HCMV
strain AD169 unspliced, singly spliced, or doubly spliced
US3 transcripts (isolated from plasmids p516, p517, p518
kindly provided by A. Colberg-Poley) (Tenney et al., 1993)
or the Towne US3-coding region (isolated from pBJ174)
(Biegalke, 1999), respectively, into the multiple cloning
site of pIRESneo (Clontech, Palo Alto, CA). pEGFP-IRES-
neo was used to generate control cell lines. Plasmid
DNA was prepared by alkaline lysis and cesium chloride
gradient centrifugation (Maniatis et al., 1982). pBJ380
was constructed by amplifying the open reading frame of
the 19-kDa US3 protein using Vent polymerase (New
England Biolabs, Beverly, MA) and oligonucleotides 133
(5 CAGGAATTCTCAGCGA AGCACTGC 3) and 222 (5
AATGGATCCTTAAATAAATCGCAGACGG 3); the result-
ing amplimer was inserted into the multiple cloning site
of pIRESneo (Clontech).
pBJ322, 323, and 521 express the proteins encoded by
the doubly spliced, singly spliced, or unspliced US3 tran-
scripts, respectively, as in-frame fusions with enhanced
green fluorescent protein. The US3-coding regions were
amplified using oligonucleotide 133 in combination with
oligonucleotide 143 (5 GACGGATCCACACCTGCAGT-
CACCACATC 3), 144 (5 CGTGGATCCCTTGCAGCCCAG-
GTAGGTTTC 3), or 259 (5 CCAGGATCCATAATAAATCG-
CAGACGGGCGC 3) and p518, p517, or p516 (Tenney et
al., 1993), respectively, as the templates. The resulting
PCR products were digested with EcoRI and BamHI and
inserted into pEGFP-IRESneo 5 of the EGFP open read-
ing frame. Junction points were sequenced to confirm the
generation of an in-frame fusion of the two open reading
frames.
Protein analysis
Proteins in US3-expressing cell lines were radiola-
beled for 30 min with 200 Ci of an [35S]methionine-
cysteine mixture (Easy Tag Express, NEN Life Science
Products, Boston, MA) using duplicate 100-mm culture
dishes. One dish of cells was lysed immediately after
labeling while the other dish was incubated with nonra-
dioactive medium for 2 h prior to lysis. For immunopre-
cipitation, cells were placed on ice and washed two
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times with cold phosphate-buffered saline. Cells were
then lysed in 500 l of lysis buffer [50 mM Tris–Cl pH 8.0,
150 mM NaCl, 0.1% SDS, 100 g/ml PMSF, 1% Nonidet
P-40, 0.5% sodium deoxycholate containing Complete
protease inhibitor (Roche Biochemical, Indianapolis, IN)].
Following incubation on ice for 2 min, cell monolayers
were harvested. Immunoprecipitation of the MHC class I
heavy chain complexes was performed using the mono-
clonal antibody W6/32 (Sigma, St. Louis, MO). Polyclonal
rabbit antisera generated to a NH2-terminal region of the
full-length US3 protein were generously provided by T. R.
Jones (1996) and were used to immunoprecipitate US3
proteins from established cell lines.
Fluorescence microscopy
EGFP fusion proteins were detected in transfected
cells using a FITC filter. The ER was labeled using a
monoclonal antibody to PDI (Stressgen, Victoria, BC,
Canada); the Golgi apparatus was labeled using a mono-
clonal antibody to human golgin-97 (Molecular Probes,
Eugene, OR). Primary antibody binding was detected
using Texas red conjugated goat anti-mouse antisera
(Molecular Probes) as the secondary antibody. Immuno-
fluorescence was performed as described (Colberg-
Poley et al., 2000). Brefeldin A was used at a concentra-
tion of 5 g/ml, with cells incubated for 1 h in medium
containing Brefeldin A. Cells were visualized using a
Nikon microscope with the appropriate fluorescence fil-
ters; images were captured using a SPOT digital camera.
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